{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:28:39Z","timestamp":1787056119501,"version":"build-2736575974"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020206","name":"Shandong Province Health Department","doi-asserted-by":"publisher","award":["1350022002"],"award-info":[{"award-number":["1350022002"]}],"id":[{"id":"10.13039\/501100020206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020206","name":"Shandong Province Health Department","doi-asserted-by":"publisher","award":["1350025030"],"award-info":[{"award-number":["1350025030"]}],"id":[{"id":"10.13039\/501100020206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020206","name":"Shandong Province Health Department","doi-asserted-by":"publisher","award":["1350023002"],"award-info":[{"award-number":["1350023002"]}],"id":[{"id":"10.13039\/501100020206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112738","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:05:31Z","timestamp":1783983931000},"page":"112738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Follicle-stimulating hormone and cancer"],"prefix":"10.1016","volume":"147","author":[{"given":"Yaohua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2025.0473","article-title":"National cancer system characteristics and global pan-cancer outcomes","volume":"11","author":"Dee","year":"2025","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0010","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0015","first-page":"111","article-title":"Cancer statistics for African American and black people, 2025","volume":"75","author":"Saka","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112738_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104536","article-title":"Lymph node metastasis in cancer: clearing the clouds to see the dawn","volume":"204","author":"Li","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cellsig.2026.112738_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113917","article-title":"The ending is not the end: lymph node metastasis in oral squamous cell carcinoma","volume":"146","author":"Wei","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112738_bb0030","article-title":"Nanotechnology-enhanced immunotherapy for metastatic cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0035","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2026.112738_bb0040","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.4103\/jpbs.jpbs_1375_24","article-title":"Innovations in cancer immunotherapy drug delivery technologies: a systematic review","volume":"17","author":"Sharma","year":"2025","journal-title":"J. Pharm. Bioallied Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112738_bb0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ijc.35455","article-title":"Neck management in cT1-2N0 oral squamous cell carcinoma: act or watchful wait?","volume":"157","author":"Li","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12951-024-02846-1","article-title":"Lymph node metastasis diagnosis of postoperative OSCC patients by analyzing extracellular vesicles in drainage fluid based on microfluidic isolation","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13048-021-00880-3","article-title":"An overview of FSH-FSHR biology and explaining the existing conundrums","volume":"14","author":"Bhartiya","year":"2021","journal-title":"J. Ovarian Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0065","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7150\/ijbs.63721","article-title":"Overview of follicle stimulating hormone and its receptors in reproduction and in stem cells and cancer stem cells","volume":"18","author":"Haldar","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0070","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0188-4409(01)00319-8","article-title":"Endocrine regulation of gonadotropin glycosylation","volume":"32","author":"Ulloa-Aguirre","year":"2001","journal-title":"Arch. Med. Res."},{"issue":"31","key":"10.1016\/j.cellsig.2026.112738_bb0075","doi-asserted-by":"crossref","first-page":"12491","DOI":"10.1073\/pnas.1206643109","article-title":"Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7656","key":"10.1016\/j.cellsig.2026.112738_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature22342","article-title":"Blocking FSH induces thermogenic adipose tissue and reduces body fat","volume":"546","author":"Liu","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112738_bb0085","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1073\/pnas.1718144115","article-title":"Epitope-specific monoclonal antibodies to FSH\u03b2 increase bone mass","volume":"115","author":"Ji","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.cellsig.2026.112738_bb0090","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1001283","article-title":"Expression of follicle-stimulating hormone receptor in tumor blood vessels","volume":"363","author":"Radu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2026.112738_bb0095","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.5114\/aoms.2015.56357","article-title":"Ectopic expression of follicle-stimulating hormone receptors in thyroid tumors","volume":"6","author":"Pawlikowski","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5603\/FHC.2012.0044","article-title":"Immunohistochemical detection of FSH receptors in pituitary adenomas and adrenal tumors","volume":"50","author":"Pawlikowski","year":"2012","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.cellsig.2026.112738_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1489767","article-title":"Targeting the FSH-FSHR axis in ovarian cancer: advanced treatment using nanotechnology and immunotherapy","volume":"15","author":"Feng","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cellsig.2026.112738_bb0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fendo.2018.00763","article-title":"Role of follicle-stimulating hormone in spermatogenesis","volume":"9","author":"Oduwole","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0188-4409(01)00328-9","article-title":"The role of follicle-stimulating hormone in spermatogenesis","volume":"32","author":"Sairam","year":"2001","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0120","doi-asserted-by":"crossref","first-page":"bqz035","DOI":"10.1210\/endocr\/bqz035","article-title":"Commentary on the recent FSH collection: known knowns and known unknowns","volume":"161","author":"Coss","year":"2020","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0125","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1210\/endo.142.6.8092","article-title":"A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions*","volume":"142","author":"Allan","year":"2001","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cellsig.2026.112738_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fendo.2019.00047","article-title":"Pharmacogenetics of FSH action in the male","volume":"10","author":"Schubert","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112738_bb0140","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1210\/en.2018-00497","article-title":"FSH actions and pregnancy: looking beyond ovarian FSH receptors","volume":"159","author":"Stilley","year":"2018","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112738_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041014","article-title":"Follicle-stimulating hormone (FSH) action on spermatogenesis: a focus on physiological and therapeutic roles","volume":"9","author":"Santi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112738_bb0150","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/clinem\/dgaa243","article-title":"Prospects for FSH treatment of male infertility","volume":"105","author":"Simoni","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2026.112738_bb0155","doi-asserted-by":"crossref","first-page":"1506450","DOI":"10.3389\/fcell.2024.1506450","article-title":"Research progress on FSH-FSHR signaling in the pathogenesis of non-reproductive diseases","volume":"12","author":"Li","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cellsig.2026.112738_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.domaniend.2019.106391","article-title":"Follicle-stimulating hormone receptors expression in ovine corpora lutea during luteal phase: effect of nutritional plane and follicle-stimulating hormone treatment","volume":"71","author":"Grazul-Bilska","year":"2020","journal-title":"Domest. Anim. Endocrinol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112738_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072270","article-title":"FSH for the treatment of male infertility","volume":"21","author":"Casarini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0170","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1530\/EC-15-0050","article-title":"FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis","volume":"4","author":"Santi","year":"2015","journal-title":"Endocr. Connect."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0175","first-page":"739","article-title":"The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology*","volume":"18","author":"Simoni","year":"1997","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112738_bb0180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40618-024-02524-x","article-title":"Current drawbacks and future perspectives in the diagnosis and treatment of male factor infertility, with a focus on FSH treatment: an expert opinion","volume":"48","author":"Santi","year":"2025","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0185","first-page":"381","article-title":"Testosterone levels after treatment with urofollitropin in infertile patients with idiopathic mild reduction of testicular volume","volume":"66","author":"La Vignera","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112738_bb0190","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1472-6483(10)60533-0","article-title":"Hormonal treatment of male infertility: FSH","volume":"15","author":"Foresta","year":"2007","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0195","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/andr.12746","article-title":"FSH treatment of male idiopathic infertility: time for a paradigm change","volume":"8","author":"Simoni","year":"2020","journal-title":"Andrology"},{"key":"10.1016\/j.cellsig.2026.112738_bb0200","first-page":"1","article-title":"Follicle-stimulating hormone receptor: advances and remaining challenges","volume":"338","author":"De Pascali","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.cellsig.2026.112738_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00148","article-title":"Biased signaling and allosteric modulation at the FSHR","volume":"10","author":"Landomiel","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41467-023-36170-3","article-title":"Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor","volume":"14","author":"Duan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112738_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.798866","article-title":"Follicle-stimulating hormone induces lipid droplets via G\u03b1i\/o and \u03b2-Arrestin in an endometrial cancer cell line","volume":"12","author":"Sayers","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2008.12.024","article-title":"Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer","volume":"278","author":"Zhang","year":"2009","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112738_bb0225","first-page":"487","article-title":"Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating EGFR\/Akt signaling pathway","volume":"35","author":"Yang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0230","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1038\/s41598-020-70896-0","article-title":"Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase","volume":"10","author":"Song","year":"2020","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112738_bb0235","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/onc.2015.316","article-title":"Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K\/AKT\/HIF-1\u03b1\/cyclin D1 pathway","volume":"35","author":"Chen","year":"2016","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112738_bb0240","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3892\/ijo.2013.2054","article-title":"Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway","volume":"43","author":"Zhang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cellsig.2026.112738_bb0245","doi-asserted-by":"crossref","first-page":"8107","DOI":"10.2147\/OTT.S173339","article-title":"Follicle-stimulating hormone inhibits cervical cancer via NF-\u03baB pathway","volume":"11","author":"Shi","year":"2018","journal-title":"Onco. Targets Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0250","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.fertnstert.2011.11.020","article-title":"Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro","volume":"97","author":"Boukaidi","year":"2012","journal-title":"Fertil. Steril."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112738_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192215344","article-title":"Follicle-stimulating hormone promotes the development of endometrial cancer in vitro and in vivo","volume":"19","author":"Sheng","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cellsig.2026.112738_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217735","article-title":"Extracellular vesicles: Hermes between cancers and lymph nodes","volume":"623","author":"Cao","year":"2025","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0265","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3892\/or.2017.5784","article-title":"Gonadotropins promote human ovarian cancer cell migration and invasion via a cyclooxygenase 2-dependent pathway","volume":"38","author":"Feng","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0270","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbrc.2015.04.061","article-title":"OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1\/2 signaling pathway in epithelial ovarian cancer","volume":"461","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112738_bb0275","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/IGC.0000000000000279","article-title":"Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K\/Akt-snail signaling pathway","volume":"24","author":"Yang","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112738_bb0280","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.7150\/thno.94161","article-title":"FSH induces EMT in ovarian cancer via ALKBH5-regulated snail m6A demethylation","volume":"14","author":"Xu","year":"2024","journal-title":"Theranostics"},{"issue":"35","key":"10.1016\/j.cellsig.2026.112738_bb0285","article-title":"ORL@cu-MOF boost cuproptosis and suppress fatty acid metabolism for cancer lymph node metastasis synergistic therapy","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167629","article-title":"Immunometabolism in head and neck squamous cell carcinoma: Hope and challenge","volume":"1871","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112738_bb0295","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41419-019-2050-y","article-title":"ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112738_bb0300","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00404-019-05100-4","article-title":"Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells","volume":"299","author":"Li","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0305","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4252\/wjsc.v7.i2.437","article-title":"Neural differentiation from embryonic stem cells in vitro: an overview of the signaling pathways","volume":"7","author":"Chuang","year":"2015","journal-title":"World J. Stem Cells"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112738_bb0310","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10815-017-1080-6","article-title":"Ovarian stem cells-resolving controversies","volume":"35","author":"Bhartiya","year":"2018","journal-title":"J. Assist. Reprod. Genet."},{"issue":"6979","key":"10.1016\/j.cellsig.2026.112738_bb0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nature02316","article-title":"Germline stem cells and follicular renewal in the postnatal mammalian ovary","volume":"428","author":"Johnson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2026.112738_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00915","article-title":"Role of OCT4 in the regulation of FSH-induced granulosa cells growth in female mice","volume":"10","author":"Heng","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112738_bb0325","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/en.2004-0548","article-title":"Formation of cystic ovarian follicles associated with elevated luteinizing hormone requires estrogen receptor-\u03b2","volume":"145","author":"Couse","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-246","article-title":"Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases","volume":"13","author":"Siraj","year":"2013","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0335","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/js.2018-00272","article-title":"Follicle-stimulating hormone is an autocrine regulator of the ovarian cancer metastatic niche through notch signaling","volume":"3","author":"Gera","year":"2019","journal-title":"J. Endocr. Soc."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0340","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1158\/1078-0432.CCR-16-0492","article-title":"Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target","volume":"23","author":"Perales-Puchalt","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112738_bb0345","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162553","article-title":"A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy","volume":"7","author":"Bordoloi","year":"2022","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112738_bb0350","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1210\/en.2018-00466","article-title":"Vascular endothelial FSH receptor, a target of interest for cancer therapy","volume":"159","author":"Ghinea","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellsig.2026.112738_bb0355","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biomaterials.2016.07.029","article-title":"In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide","volume":"104","author":"Yang","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112738_bb0360","article-title":"Antibody selection for cancer target validation of FSH-receptor in immunohistochemical settings","volume":"6","author":"Moeker","year":"2017","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.cellsig.2026.112738_bb0365","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fendo.2019.00032","article-title":"Extragonadal FSHR expression and function-is it real?","volume":"10","author":"Chrusciel","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cellsig.2026.112738_bb0370","article-title":"A follicle-stimulating hormone receptor-targeted near-infrared fluorescent probe for tumor-selective imaging and photothermal therapy","volume":"24","author":"Liu","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.cellsig.2026.112738_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2674502","article-title":"PET imaging of FSHR expression in tumors with 68Ga-labeled FSH1 peptide","volume":"2017","author":"Pan","year":"2017","journal-title":"Contrast Media Mol. Imaging"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112738_bb0380","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/mp500766x","article-title":"PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging","volume":"12","author":"Hong","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cellsig.2026.112738_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125334","article-title":"Follicle-stimulating hormone peptide-conjugated liposomes in the treatment of epithelial ovarian cancer through the induction of M2-to-M1 macrophage repolarization","volume":"672","author":"Hu","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112738_bb0390","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.3390\/cancers17233850","article-title":"Pancreatic cancer organoids: modeling disease and guiding therapy","volume":"17","author":"Morceau","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112738_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27093790","article-title":"Harnessing cancer stem cells and 3D organoids in unravelling spatial and cellular heterogeneity in cancer","volume":"27","author":"Kwak","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112738_bb0400","doi-asserted-by":"crossref","first-page":"1515340","DOI":"10.3389\/fbioe.2025.1515340","article-title":"Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling","volume":"13","author":"Papamichail","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.cellsig.2026.112738_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122868","article-title":"Engineered nano-carrier systems for the oral targeted delivery of follicle stimulating Hormone: development, characterization, and, assessment of in vitro and in vivo performance and targetability","volume":"637","author":"Raut","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cellsig.2026.112738_bb0410","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejps.2017.07.007","article-title":"Follicle-stimulating hormone encapsulation in the cholesterol-modified chitosan nanoparticles via molecular dynamics simulations and binding free energy calculations","volume":"107","author":"Yahyaei","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0415","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/10717544.2018.1440667","article-title":"Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-\u03b1 silencing and antitumor activity against ovarian cancer","volume":"25","author":"Hong","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112738_bb0420","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/10717544.2018.1461956","article-title":"Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112738_bb0425","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1039\/C3NR05042D","article-title":"Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells","volume":"6","author":"Modi","year":"2014","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112738_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040490","article-title":"Synergistic effects of chemotherapy and phototherapy on ovarian cancer using follicle-stimulating hormone receptor-mediated liposomes co-loaded with SN38 and IR820","volume":"16","author":"Pian","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:45:01Z","timestamp":1787053501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826003955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":86,"alternative-id":["S0898656826003955"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112738","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicle-stimulating hormone and cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112738"}}